Several genetic aberrations frequently detected in GBM, such as mutations in the p53 gene, Egfr overexpression or amplification, and deletion of the p16/Cdkn2A gene, are also associated with poor prognosis in both ODG and OAC. The gene discussed is TP53; the disease is glioblastoma.